NCT03386552View on ClinicalTrials.gov

A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility

PHASE2UnknownINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 20, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

March 31, 2019

Conditions

Unexplained Infertility

Interventions

DRUG

Isifera+

Pertubation solution of lidocaine 0.5 mg ml in Ringer-Acetate buffer

DRUG

Buffer

Pertubation solution of Ringer-Acetate buffer

Trial Locations (1)

02-532

RECRUITING

InviMed-T sp. z o.o, Warsaw

Sponsors

Collaborators (1)

Ferring Pharmaceuticals

All Listed Sponsors

collaborator

Ferring Pharmaceuticals

INDUSTRY

collaborator

Vinnova

OTHER_GOV

lead

Isifer AB

INDUSTRY

NCT03386552 - A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility | Biotech Hunter | Biotech Hunter